IFORMULATE Trademark

Trademark Overview


On Saturday, May 15, 2021, a trademark application was filed for IFORMULATE with the United States Patent and Trademark Office. The USPTO has given the IFORMULATE trademark a serial number of 90713374. The federal status of this trademark filing is REGISTERED as of Tuesday, May 31, 2022. This trademark is owned by HTD Biosystems, Inc.. The IFORMULATE trademark is filed in the Chemical Products and Computer & Software Services & Scientific Services categories with the following description:

Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of liquid formulations of proteins, antibodies, peptides, and other small molecules, and for use in evaluating their respective solubility properties, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of nanoparticle formulations, including investigating parameters related to drug release, particle size, aggregations, and drug integrity, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of vaccine stability formulations, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in ...

Scientific research services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy; Scientific laboratory services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy
iformulate

General Information


Serial Number90713374
Word MarkIFORMULATE
Filing DateSaturday, May 15, 2021
Status700 - REGISTERED
Status DateTuesday, May 31, 2022
Registration Number6743350
Registration DateTuesday, May 31, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 15, 2022

Trademark Statements


Pseudo MarkI FORMULATE
Goods and ServicesPre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of liquid formulations of proteins, antibodies, peptides, and other small molecules, and for use in evaluating their respective solubility properties, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of nanoparticle formulations, including investigating parameters related to drug release, particle size, aggregations, and drug integrity, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of vaccine stability formulations, all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of antibody conjugates and antibody drug conjugates (ADCs), all the foregoing using Design of Experiments Approach in a multivariate fashion; Pre-designed biochemical preparations for use in evaluating biopharmaceutical drug formulations in the nature of diagnostic reagents and for use in evaluating their stability and compatibility in various formulations with respect to the effect of pH, ionic strength, buffer and stability concentrations, all the foregoing using Design of Experiments Approach in a multivariate fashion
Goods and ServicesScientific research services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy; Scientific laboratory services related to providing an optimum process for identifying stable formulations for biotech drugs such as protein, peptides, and small molecules, using advanced Design of Experiments strategy

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, August 13, 2021
Primary Code001
First Use Anywhere DateMonday, June 28, 2010
First Use In Commerce DateMonday, June 28, 2010

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, August 13, 2021
Primary Code042
First Use Anywhere DateSunday, March 28, 2010
First Use In Commerce DateMonday, June 28, 2010

Trademark Owner History


Party NameHTD Biosystems, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94566

Party NameHTD Biosystems, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94566

Party NameHTD Biosystems, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPleasanton, CA 94566

Trademark Events


Event DateEvent Description
Thursday, April 20, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 20, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, April 20, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 20, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 31, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 31, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, March 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, February 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 10, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, February 8, 2022ASSIGNED TO LIE
Friday, February 4, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, January 31, 2022EXAMINER'S AMENDMENT ENTERED
Monday, January 31, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, January 31, 2022EXAMINERS AMENDMENT E-MAILED
Monday, January 31, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 25, 2022ASSIGNED TO EXAMINER
Friday, August 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 19, 2021NEW APPLICATION ENTERED